BRISTOL-MYERS SQUIBB COMPANY Other Non-Current Liabilities
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Other Non-Current Liabilities of $4.34 billion as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-07-30
- 2026-06-30: Other Liabilities, Noncurrent $4.34B.
- 2026-03-31: Other Liabilities, Noncurrent $4.85B.
- 2025-12-31: Other Liabilities, Noncurrent $5.04B.
- 2025-09-30: Other Liabilities, Noncurrent $5.46B.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $4.34B 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $4.85B 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $5.04B 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $5.46B 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $4.94B 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $4.48B 10-Q · filed 2025-04-24 | |
| 2024-12-31 | $4.47B 10-K · filed 2026-02-11 | |
| 2024-09-30 | $4.73B 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $4.99B 10-Q · filed 2024-07-26 | |
| 2024-03-31 | $6.73B 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $6.42B 10-K · filed 2025-02-12 | |
| 2023-09-30 | $6.20B 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $5.90B 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $6.66B 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $6.59B 10-K · filed 2024-02-13 | |
| 2022-09-30 | $6.68B 10-Q · filed 2022-10-26 | |
| 2022-06-30 | $6.64B 10-Q · filed 2022-07-27 | |
| 2022-03-31 | $7.31B 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $7.33B 10-K · filed 2023-02-14 | |
| 2021-09-30 | $7.52B 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $7.50B 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $7.69B 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $7.78B 10-K · filed 2022-02-09 | |
| 2020-09-30 | $7.57B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $7.49B 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $10.70B 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $10.10B 10-K · filed 2021-02-10 | |
| 2019-09-30 | $1.88B 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $1.90B 10-Q · filed 2019-07-25 | |
| 2019-03-31 | $1.51B 10-Q · filed 2019-04-25 | |
| 2018-12-31 | $4.54B 10-K · filed 2020-02-24 | $1.05B 10-K · filed 2019-02-25 |
| 2018-09-30 | $1.00B 10-Q · filed 2018-10-25 | |
| 2018-06-30 | $1.07B 10-Q · filed 2018-07-26 | |
| 2018-03-31 | $1.10B 10-Q · filed 2018-04-26 | |
| 2017-12-31 | $1.16B 10-K · filed 2019-02-25 | |
| 2017-09-30 | $1.16B 10-Q · filed 2017-10-26 | |
| 2017-06-30 | $1.18B 10-Q · filed 2017-07-27 | |
| 2017-03-31 | $1.20B 10-Q · filed 2017-04-27 | |
| 2016-12-31 | $1.28B 10-K · filed 2018-02-13 | |
| 2016-09-30 | $1.64B 10-Q · filed 2016-10-27 | |
| 2016-06-30 | $1.80B 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $1.69B 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $1.43B 10-K · filed 2017-02-21 | $480.00M 10-K · filed 2016-02-12 |
| 2015-09-30 | $468.00M 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $475.00M 10-Q · filed 2015-07-23 | |
| 2015-03-31 | $583.00M 10-Q · filed 2015-04-28 | |
| 2014-12-31 | $618.00M 10-K · filed 2016-02-12 | |
| 2014-09-30 | $618.00M 10-Q · filed 2014-10-24 | |
| 2014-06-30 | $624.00M 10-Q · filed 2014-07-24 | |
| 2014-03-31 | $616.00M 10-Q · filed 2014-04-29 | |
| 2013-12-31 | $625.00M 10-K · filed 2015-02-13 | |
| 2013-09-30 | $665.00M 10-Q · filed 2013-10-23 | |
| 2013-06-30 | $649.00M 10-Q · filed 2013-07-25 | |
| 2013-03-31 | $459.00M 10-Q · filed 2013-04-25 | |
| 2012-12-31 | $475.00M 10-K · filed 2014-02-14 | |
| 2012-09-30 | $464.00M 10-Q · filed 2012-10-24 | |
| 2012-06-30 | $703.00M 10-Q · filed 2012-07-25 | |
| 2012-03-31 | $656.00M 10-Q · filed 2012-04-26 | |
| 2011-12-31 | $384.00M 10-K · filed 2013-02-15 | $491.00M 10-K · filed 2012-02-17 |
| 2011-09-30 | $467.00M 10-Q · filed 2011-10-27 | |
| 2011-06-30 | $443.00M 10-Q · filed 2011-07-28 | |
| 2011-03-31 | $438.00M 10-Q · filed 2011-04-28 | |
| 2010-12-31 | $424.00M 10-K · filed 2012-02-17 | |
| 2010-09-30 | $409.00M 10-Q · filed 2010-10-26 | |
| 2010-06-30 | $409.00M 10-Q · filed 2010-07-22 | |
| 2010-03-31 | $416.00M 10-Q · filed 2010-04-29 | |
| 2009-12-31 | $422.00M 10-K · filed 2011-02-18 | |
| 2009-09-30 | $408.00M 10-Q · filed 2009-10-22 | |
| 2009-06-30 | $430.00M 10-Q · filed 2009-07-23 | |
| 2008-12-31 | $441.00M 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |